Microbial Host Cells for Hydroxytyrosol Production via Enzymatic Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing hydroxytyrosol are inefficient and result in low purity due to the complexity of olive extracts and the slow microbial conversion of tyrosine to L-DOPA, with over-oxidation issues and limited availability of tetrahydrobiopterin cofactor in microbial systems.
Innovation Solution
A biotechnological approach involving genetically modified host cells capable of producing L-DOPA and converting it to hydroxytyrosol, using enzymes like tyrosine hydroxylase, dihydropteridine reductase, and pterin-4-alpha-carbinolamine dehydratase, with a co-culture strategy to enhance production efficiency and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tyrosinase is used for microbial conversion of tyrosine to L-DOPA, then the reaction can proceed under mild conditions, but the conversion is slow and over-oxidation to ortho-quinone is difficult to avoid
Solution Approach 1:
The patent introduces a two-enzyme system where tyrosine hydroxylase (TH) acts as the primary enzyme for L-DOPA synthesis with tetrahydrobiopterin (BH4) as cofactor, and ascorbic acid reductase (AAR) serves as a protective intermediary that reduces ortho-quinone back to L-DOPA. This intermediary mechanism prevents irreversible over-oxidation while maintaining fast conversion speed, resolving the contradiction between productivity and product purity.
Solution Approach 2:
The patent changes the biochemical parameters by introducing ascorbic acid as a cofactor for AAR and optimizing the pH and temperature conditions for the two-enzyme system. This parameter optimization allows the system to achieve both high conversion speed and high product purity by controlling the redox balance and preventing over-oxidation side reactions.
2Productivity
If chemical hydrolysis of olive extracts is used to produce hydroxytyrosol, then production can proceed, but the product purity is low due to complexity of olive extracts
Solution Approach 1:
The patent extracts only the necessary enzymatic components (TH and AAR) from complex biological systems and implements them in a simplified microbial expression system. This extraction approach eliminates the complex mixture of compounds present in olive extracts, allowing high-productivity chemical hydrolysis to proceed while achieving high product purity through the specificity of the engineered enzymatic pathway.
Solution Approach 2:
The patent creates a synthetic copy of the natural hydroxytyrosol production pathway by expressing plant-derived TH and AAR genes in microbial hosts. This copied pathway reproduces the desired transformation with high efficiency and specificity, achieving both high productivity and high manufacturing precision that cannot be obtained from direct processing of olive extracts.
3Reliability
If tetrahydrobiopterin cofactor is used in tyrosine hydroxylase reaction, then over-oxidation is prevented, but the cofactor is not naturally available in microbial systems
Solution Approach 1:
The patent introduces ascorbic acid reductase (AAR) as an intermediary enzyme that uses ascorbic acid (a readily available cofactor in microbial systems) to reduce ortho-quinone back to L-DOPA. This intermediary mechanism compensates for the unavailability of tetrahydrobiopterin in microbes while still preventing over-oxidation, thus maintaining reliability without compromising ease of manufacture.
Solution Approach 2:
The patent changes the cofactor system from tetrahydrobiopterin (not available in microbes) to ascorbic acid (naturally available in microbial systems). This parameter change maintains the protective function against over-oxidation while improving ease of manufacture, as ascorbic acid can be supplied in the growth medium without requiring complex cofactor biosynthesis pathways.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Significantly improves hydroxytyrosol production titer and purity by optimizing the metabolic pathway, achieving higher yields and overcoming over-oxidation challenges, with potential for industrial-scale microbial fermentation.
Implementation Method 1
The first oxidation step is o-hydroxylation of L-tyrosine to L-DOPA
Implementation Method 2
L-DOPA is an important compound to living cells, especially in animal since it is used as a precursor for many neurotransmitters, and in animal brain, L-DOPA was synthesized by tyrosine hydroxylase (TH) with tetrahydrobiopterin (BH4) as a cofactor
Implementation Method 3
L-DOPA is converted into dopamine by L-DOPA decarboxylase (DDC)
Implementation Method 4
dopamine is converted into hydroxytyrosol by monoamine oxidase (MAO)
Implementation Method 5
The aldehyde is then converted into hydroxytyrosol by alcohol dehydrogenase (ADH) using NADH as a cofactor
Data Source
AI summary
The present invention provides for a composition comprising: (a) a first host cell capable of producing L-DOPA; and (b) a modified host cell is capable of converting L-DOPA into hydroxytyrosol (HTy); wherein any one or both of the first host cell and second host cell is a genetically modified host cell.